Janux Therapeutics Inc (JANX)
NASDAQ:JANX
US Market

Janux Therapeutics Inc (JANX) Income Statement

Compare
373 Followers

Janux Therapeutics Inc Income Statement

Last quarter (Q4 2024), Janux Therapeutics Inc's total revenue was $0.00, a decrease of -100.00% from the same quarter last year. In Q4, Janux Therapeutics Inc's net income was $-20.22M. See Janux Therapeutics Inc’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 10.59M$ 8.08M$ 8.61M$ 3.64M$ 0.00
Gross Profit
$ 10.59M$ 6.13M$ 7.77M$ 3.52M$ -13.00K
Operating Expenses
$ 109.44M$ 81.06M$ 75.70M$ 36.57M$ 4.84M
Depreciation and Amortization
$ 0.00$ 1.96M$ 841.00K$ 113.00K$ 13.00K
EBITDA
$ -98.85M$ -71.02M$ -66.25M$ -32.82M$ -4.83M
Operating Income
$ -98.85M$ -72.98M$ -67.09M$ -32.93M$ -4.84M
Other Income/Expenses
$ 29.85M$ 14.69M$ 4.03M$ 257.00K$ -1.94M
Pretax Income
$ -68.99M$ -58.29M$ -63.06M$ -32.67M$ -6.78M
Net Income
$ -68.99M$ -58.29M$ -54.15M$ -32.56M$ -5.25M
Per Share Metrics
Basic EPS
$ -1.28$ -1.32$ -1.31$ -0.79$ -0.13
Diluted EPS
$ -1.28$ -1.32$ -1.31$ -0.79$ -0.13
Weighted Average Shares Outstanding
53.75M 44.02M 41.47M 41.24M 41.61M
Weighted Average Shares Outstanding (Diluted)
53.75M 44.02M 41.47M 41.24M 41.61M
Currency in USD

Janux Therapeutics Inc Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis